Tofacitinib For The Treatment Of Patients With Juvenile Idiopathic Arthritis: An Interim Analysis Of Data Up To 5.5 Years From An Open-Label, Long-Term Extension Study

ARTHRITIS & RHEUMATOLOGY(2020)

引用 4|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要